Production (Stage)
Acutus Medical, Inc.
AFIB
$0.0105
$0.01035,150.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 88.31% | -27.80% | -23.91% | -320.81% | -106.14% |
| Total Depreciation and Amortization | 17.51% | 122.19% | 141.04% | 308.77% | -27.65% |
| Total Amortization of Deferred Charges | 63.05% | 62.67% | 54.63% | -3.82% | -32.82% |
| Total Other Non-Cash Items | -223.96% | 126.37% | 90.10% | 106.53% | 133.20% |
| Change in Net Operating Assets | -537.66% | -220.51% | -562.63% | -186.25% | 135.04% |
| Cash from Operations | 49.84% | 26.39% | 19.31% | 16.51% | 29.01% |
| Capital Expenditure | 48.86% | -22.50% | -41.80% | -135.81% | 3.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 9.84% | -64.23% | -72.23% | -91.61% | -75.71% |
| Other Investing Activities | -91.41% | -35.61% | 277.63% | 181.67% | 19.43% |
| Cash from Investing | -62.17% | -53.16% | -8.92% | -49.49% | -44.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -43.55% | -43.55% | 62.16% | -77.22% |
| Repurchase of Common Stock | -- | -- | 86.52% | 68.47% | 68.47% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 90.12% | 65.64% | -49,780.00% | -26.66% | -30.66% |
| Cash from Financing | -8.52% | -87.71% | -2,361.84% | 78.85% | 77.07% |
| Foreign Exchange rate Adjustments | -89.37% | -22.93% | -16.04% | 28.16% | -28.53% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -136.62% | -1,684.20% | 19.02% | -165.59% | -172.23% |